Form 4: MAXIMUS Director Anne Altman Receives RSU Grant
Insider Transaction Report
MAXIMUS Director Anne K. Altman was granted 3,062 restricted stock units, vesting in one year.
Summary
- Anne K. Altman, a Director at MAXIMUS, INC. (MMS), acquired 3,062 shares of common stock on March 10, 2026.
- The acquisition represents a grant of restricted stock units (RSUs) with a price of $0 per unit.
- These RSUs are scheduled to vest one year from the date of grant.
- Following this transaction, Anne K. Altman beneficially owns a total of 35,141.897 shares.
- The total beneficial ownership includes 13.83 dividend equivalent rights accrued on previously-awarded RSUs, which vest proportionately with their related RSUs.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a slightly positive event, as it represents a routine equity grant to a director, which generally enhances alignment between management and shareholder interests without indicating any significant operational or financial changes.
Positives
- The grant of restricted stock units to a director aligns their interests with those of the shareholders, encouraging long-term value creation.
Future Outlook
The granted restricted stock units are expected to vest one year from the grant date, indicating a future increase in the director's vested equity holdings.
Industry Context
StockSavvy.ai notes that RSU grants are a common form of non-cash compensation for directors and executives across various industries. This practice is designed to align the interests of company leadership with those of shareholders by tying a portion of their compensation to the company's long-term stock performance.
Comparison to Industry Standards
- StockSavvy.ai observes that RSU grants are a standard practice across industries for director compensation, similar to grants seen at companies like IBM or Accenture for their board members, aiming to foster long-term commitment and performance alignment.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Administrative Authorization | A Power of Attorney was executed on March 9, 2026, appointing Jason Frank, David Mutryn, and Theresa Golinvaux as attorneys-in-fact for Anne K. Altman to execute and file Forms 3, 4, and 5 with the SEC. This streamlines compliance with Section 16(a) of the Securities Exchange Act of 1934. | 03/09/2026 | This is an administrative measure to facilitate timely and accurate SEC filings for insider transactions, enhancing compliance efficiency rather than indicating a substantive change in corporate governance policy or structure. |
Stakeholder Impact
- Shareholders: The RSU grant aligns the director's financial interests with long-term shareholder value, potentially fostering more shareholder-centric decision-making.
- Director (Anne K. Altman): This grant represents a component of her compensation package, increasing her equity stake in the company.
Next Steps
- The granted restricted stock units are scheduled to vest one year from the grant date of March 10, 2026.
Key Dates
| Date | Description |
|---|---|
| 03/09/2026 | Date of execution for the Power of Attorney document. |
| 03/10/2026 | Date of the RSU grant transaction. |
| 03/12/2026 | Date the Form 4 was signed by the Attorney-In-Fact. |
Recommendation
holdThis Form 4 reports a routine grant of restricted stock units to a director, which is a standard compensation practice. While it aligns the director's interests with shareholders, it does not provide sufficient new information to warrant a change in investment recommendation based solely on this filing.
Keywords
MAXIMUS, MMS, Anne K. Altman, Restricted Stock Units, RSU Grant, Insider Transaction, Director Compensation, SEC Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.